Skip to Main Content

Author Details

Cameron Herberts
University of British Columbia
2018
16
10
PMIDPaper TitleJournal TitlePublished Year
36914848A generalizable machine learning framework for classifying DNA repair defects using ctDNA exomes.NPJ Precis Oncol2023
37207301Genetic and Genomic Testing for Prostate Cancer: Beyond DNA Repair.Am Soc Clin Oncol Educ Book2023
36996325Early On-treatment Changes in Circulating Tumor DNA Fraction and Response to Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer.Clin Cancer Res2023
34895867Somatic Features of Response and Relapse in Non-muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy.Eur Urol Oncol2022
35507889Genomic Features of Lung-Recurrent Hormone-Sensitive Prostate Cancer.JCO Precis Oncol2022
35859180Deep whole-genome ctDNA chronology of treatment-resistant prostate cancer.Nature2022
36251389The 5-Hydroxymethylcytosine Landscape of Prostate Cancer.Cancer Res2022
33414135<i>BRCA2</i>, <i>ATM</i>, and <i>CDK12</i> Defects Differentially Shape Prostate Tumor Driver Genomics and Clinical Aggression.Clin Cancer Res2021
34219051Technical and biological constraints on ctDNA-based genotyping.Trends Cancer2021
34083234Evolution of Castration-Resistant Prostate Cancer in ctDNA during Sequential Androgen Receptor Pathway Inhibition.Clin Cancer Res2021
32451180Activating AKT1 and PIK3CA Mutations in Metastatic Castration-Resistant Prostate Cancer.Eur Urol2020
31744831Identification of Hypermutation and Defective Mismatch Repair in ctDNA from Metastatic Prostate Cancer.Clin Cancer Res2020
30638634Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.Eur Urol2019
31585777Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.Urol Oncol2019
31358384Morphologic and genomic characterization of urothelial to sarcomatoid transition in muscle-invasive bladder cancer.Urol Oncol2019
30015382Biallelic tumour suppressor loss and DNA repair defects in de novo small-cell prostate carcinoma.J Pathol2018
  • 1 - 16 of 16

Recommended Authors

Lydia Y Liu
University of Toronto
Career Start Year 2018
Number of shared co-authors 3
Job van Riet
Erasmus MC Cancer Institute
Career Start Year 2017
Number of shared co-authors 7
Shadrielle Melijah G Espiritu
Ontario Institute for Cancer Research
Career Start Year 2017
Number of shared co-authors 5
Minke Smits
Radboud University Medical Center
Career Start Year 2017
Number of shared co-authors 5
Edward O'Connor
Dana-Farber Cancer Institute
Career Start Year 2017
Number of shared co-authors 10
Vincent Huang
Ontario Institute for Cancer Research
Career Start Year 2016
Number of shared co-authors 8
Lisanne F van Dessel
Erasmus MC Cancer Institute
Career Start Year 2015
Number of shared co-authors 5
Takafumi N Yamaguchi
University of California los angeles
Career Start Year 2015
Number of shared co-authors 8
Wei Yuan
The Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 6
Veronica Y Sabelnykova
Ontario Institute for Cancer Research
Career Start Year 2015
Number of shared co-authors 3
Daniel H Hovelson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2014
Number of shared co-authors 5
Joshua Armenia
Oncology R&D
Career Start Year 2013
Number of shared co-authors 5
Niedzica Camacho
Memorial Sloan Kettering Cancer Center
Career Start Year 2013
Number of shared co-authors 2
Ryan Dittamore
Decipher Biosciences Inc.
Career Start Year 2013
Number of shared co-authors 17
Dan R Robinson
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2011
Number of shared co-authors 8
Julie Livingstone
University of California los angeles
Career Start Year 2011
Number of shared co-authors 19
Adam G Sowalsky
National Cancer Institute
Career Start Year 2010
Number of shared co-authors 14
Eliezer M Van Allen
Dana-Farber Cancer Institute
Career Start Year 2009
Number of shared co-authors 19
Mohammed Alshalalfa
University of Miami Miller School of Medicine/Sylvester Comprehensive Cancer Center
Career Start Year 2009
Number of shared co-authors 29
Susana Miranda
The Institute of Cancer Research
Career Start Year 2008
Number of shared co-authors 6
Mark M Pomerantz
Dana-Farber Cancer Institute
Career Start Year 2007
Number of shared co-authors 20
Robert J Lonigro
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2007
Number of shared co-authors 7
Alok K Tewari
Dana-Farber Cancer Institute, Harvard Medical School
Career Start Year 2005
Number of shared co-authors 3
Christopher E Barbieri
Weill Cornell Medical College
Career Start Year 2003
Number of shared co-authors 13
Daniel Leongamornlert
Oncogenetics Team The Institute of Cancer Research London UK.
Career Start Year 2003
Number of shared co-authors 4
Scott A Tomlins
Rogel Cancer Center, University of Michigan Medical School ann arbor
Career Start Year 2003
Number of shared co-authors 35
Wassim Abida
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 14
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Career Start Year 1999
Number of shared co-authors 7
Colin C Pritchard
University of Washington, USA Brotman Baty Institute for Precision Medicine
Career Start Year 1999
Number of shared co-authors 29
Joaquin Mateo
Vall d'Hebron Institute of Oncology, Vall d'Hebron University Hospital Campus
Career Start Year 1997
Number of shared co-authors 22

Collaborators

Alexander W Wyatt
University of British Columbia
Co-authored papers 16
Matti Annala
University of British Columbia
Co-authored papers 13
Kim N Chi
University of British Columbia
Co-authored papers 9
Elie Ritch
University of British Columbia
Co-authored papers 9
Martin E Gleave
University of British Columbia
Co-authored papers 5
Matti Nykter
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 4
Sinja Taavitsainen
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Co-authored papers 3
Ladan Fazli
University of British Columbia
Co-authored papers 3
Corinne Maurice-Dror
Institute of Oncology
Co-authored papers 2
Rahul Aggarwal
University of California San Francisco
Co-authored papers 2
Felix Y Feng
UCSF Medical Center-Mount Zion
Co-authored papers 2
David A Quigley
University of California-San Francisco
Co-authored papers 2
Elai Davicioni
Veracyte Inc.
Co-authored papers 2
Yang Liu
Veracyte inc.
Co-authored papers 2
Antonio Hurtado-Coll
University of British Columbia
Co-authored papers 2
Eric J Small
University of California san francisco
Co-authored papers 2
Yuzhuo Wang
University of British Columbia
Co-authored papers 1
Samuel Levy
Bluestar Genomics Inc.
Co-authored papers 1
Junjie T Hua
School of Public Health, Sun Yat-sen University
Co-authored papers 1
Tierney Phillips
Bluestar Genomics Inc.
Co-authored papers 1
Housheng Hansen He
Princess Margaret Cancer Center, University Health Network, University of Toronto
Co-authored papers 1
Sarah W S Ng
University of British Columbia
Co-authored papers 1
Paul Lloyd
Bluestar Genomics Inc.
Co-authored papers 1
Erin McCarthy
Bluestar Genomics Inc.
Co-authored papers 1
Arian Lundberg
University of California san francisco
Co-authored papers 1
Hui Xue
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Co-authored papers 1
Niven Mehra
Radboud university medical center
Co-authored papers 1
Fred Saad
University of Montreal Health Center
Co-authored papers 1
Jianhua Luo
University of Pittsburgh
Co-authored papers 1
Steven J M Jones
University of British Columbia
Co-authored papers 1
Release 1.2